Investigation Into Anavex Life Sciences Corp. (AVXL)
ATLANTA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Anavex Life Sciences Corp. (“Anavex” or the “Company”)...
Stay updated with breaking news from Corey Holzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ATLANTA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Anavex Life Sciences Corp. (“Anavex” or the “Company”)...
ATLANTA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL) complied with federal securities laws. On January 2,
ATLANTA, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Milestone Pharmaceuticals Inc. (“Milestone Pharmaceuticals”...
ATLANTA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against VNET Group ("VNET" or the "Company") (NASDAQ:VNET). The lawsuit
ATLANTA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Eagle Pharmaceuticals, Inc. (“Eagle Pharmaceuticals” or the